Adderall and Breastfeeding
Adderall (mixed amphetamine salts) can be used during breastfeeding with careful infant monitoring, as current evidence suggests breastfeeding does not seem to adversely affect infants when amphetamines are used therapeutically for ADHD. 1
Evidence-Based Recommendation
The most recent 2024 American Journal of Obstetrics and Gynecology guidelines provide clear guidance on amphetamine use during lactation. The consensus is that treatment with medications should not be stopped if they are required for the daily functioning of the breastfeeding person, as the magnitude of documented risks is very low. 1
Key Safety Data
Hale Lactation Risk Category: L3 (moderately safe) 1
The guideline explicitly states that when amphetamines are used therapeutically (not recreationally), breastfeeding does not appear to adversely affect infants 1. This is supported by:
- Limited but reassuring research data: A 2024 pilot study of 13 children exposed to amphetamine stimulants during breastfeeding showed normal neurodevelopment with no significant adverse effects 2
- Low infant exposure: Studies show relative infant doses (RID) around 2-5.7%, well below the 10% threshold generally considered safe 3, 4
- Minimal infant plasma levels: Breastfed infants had low plasma concentrations (approximately 9% of maternal levels) despite extensive milk transfer 3
Clinical Implementation Algorithm
If amphetamine treatment is necessary for maternal functioning:
- Continue therapeutic dose at delivery and during breastfeeding 1
- Discuss breastfeeding safety with the patient, including risk-benefit considerations 1
- Consider intermittent use and timing feedings/pumping to achieve lowest concentration in breast milk 1
- Monitor infant carefully for: 1
- Irritability
- Insomnia/sleep disturbances
- Feeding difficulty
- Appropriate weight gain
- Meeting developmental milestones
Important Caveats
The FDA label states that mothers should not breastfeed during Adderall treatment 5, which represents the most conservative regulatory position. However, this conflicts with current clinical guidelines that take a more nuanced, evidence-based approach recognizing that untreated ADHD can significantly impair maternal functioning and quality of life.
Critical distinction: All safety information applies only to therapeutic, prescribed amphetamine use for ADHD—not to recreational methamphetamine abuse, which carries entirely different risks 1
Alternative Considerations
If concerns persist about amphetamine use:
- Methylphenidate may be preferred as it has more extensive breastfeeding safety data with RIDs <1% and is generally undetected in infant blood 1
- Bupropion is another option with established perinatal safety data, though less efficacious than stimulants for ADHD 1
Practical Monitoring
Ensure infants are:
- Gaining weight appropriately
- Meeting age-appropriate developmental milestones
- Not showing signs of stimulant effects (agitation, poor sleep, feeding problems)
- Evaluated regularly in early months 1
The evidence supports continuing Adderall during breastfeeding when medically necessary, with appropriate infant monitoring, rather than forcing mothers to choose between treating their ADHD and breastfeeding their infants.